BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27038124)

  • 21. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Obesity and Metabolic Abnormalities on the Risk of Developing Colorectal Neoplasia.
    Kim NH; Jung YS; Park JH; Park DI; Sohn CI
    Dig Dis Sci; 2018 Nov; 63(11):3126-3133. PubMed ID: 30094620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status.
    Huh JH; Kim KJ; Kim SU; Han SH; Han KH; Cha BS; Chung CH; Lee BW
    Metabolism; 2017 Jan; 66():23-31. PubMed ID: 27923446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of obesity phenotypes with electrocardiographic subclinical myocardial injury in the general population.
    Vasim I; Ahmad MI; Mongraw-Chaffin M; Soliman EZ
    Clin Cardiol; 2019 Mar; 42(3):373-378. PubMed ID: 30652323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    Kang YM; Jung CH; Cho YK; Lee SE; Lee MJ; Hwang JY; Kim EH; Park JY; Lee WJ; Kim HK
    PLoS One; 2017; 12(4):e0175762. PubMed ID: 28419118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostically Distinct Phenotypes of Metabolic Health Beyond Obesity in Aortic Stenosis.
    Chew NWS; Zhang A; Kong G; Lee KL; Ng CH; Chong B; Ngiam JN; Sia CH; Loh PH; Lim Y; Kuntjoro I; Wong RC; Kong WK; Yeo TC; Poh KK
    Am J Cardiol; 2022 Sep; 178():112-118. PubMed ID: 35764427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation.
    Jung CH; Lee MJ; Kang YM; Jang JE; Leem J; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    J Clin Endocrinol Metab; 2015 Mar; 100(3):934-41. PubMed ID: 25490279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort.
    Wang Y; Lin H; Li Q; Guan L; Zhao M; Zhong F; Liu J; Yuan Z; Guo H; Song Y; Gao L; Zhao J
    Endocrine; 2021 Jun; 72(3):688-698. PubMed ID: 33818715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the risk of hypertension according to the metabolic health status stratified by degree of obesity.
    Ryoo JH; Park SK; Oh CM; Choi YJ; Chung JY; Ham WT; Jung T
    J Am Soc Hypertens; 2017 Jan; 11(1):20-27.e4. PubMed ID: 27866959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolically healthy versus unhealthy obese phenotypes in relation to hypertension incidence; a prospective cohort study.
    Hamzeh B; Pasdar Y; Moradi S; Darbandi M; Rahmani N; Shakiba E; Najafi F
    BMC Cardiovasc Disord; 2022 Mar; 22(1):106. PubMed ID: 35287586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic Health, Obesity, and the Risk of Developing Open-Angle Glaucoma: Metabolically Healthy Obese Patients versus Metabolically Unhealthy but Normal Weight Patients.
    Jung Y; Han K; Park HYL; Lee SH; Park CK
    Diabetes Metab J; 2020 Jun; 44(3):414-425. PubMed ID: 31950773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The risk of Alzheimer's disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    Aging (Albany NY); 2021 Jul; 13(13):16974-16989. PubMed ID: 34237705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
    Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Prevalence of Metabolically Healthy and Unhealthy Obesity according to Different Criteria.
    Liu C; Wang C; Guan S; Liu H; Wu X; Zhang Z; Gu X; Zhang Y; Zhao Y; Tse LA; Fang X
    Obes Facts; 2019; 12(1):78-90. PubMed ID: 30814477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals.
    Ahl S; Guenther M; Zhao S; James R; Marks J; Szabo A; Kidambi S
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4172-80. PubMed ID: 26401592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolically healthy obesity and risk of leukoaraiosis; a population based cross-sectional study.
    Okamura T; Hashimoto Y; Hamaguchi M; Ohbora A; Kojima T; Fukui M
    Endocr J; 2018 Jun; 65(6):669-675. PubMed ID: 29643322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study.
    Lee YB; Kim DH; Kim SM; Kim NH; Choi KM; Baik SH; Park YG; Han K; Yoo HJ
    Cardiovasc Diabetol; 2020 Jun; 19(1):77. PubMed ID: 32534576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the levels of inflammatory markers between metabolically healthy obese and other obesity phenotypes in adults: A systematic review and meta-analysis.
    Su Z; Efremov L; Mikolajczyk R
    Nutr Metab Cardiovasc Dis; 2024 Feb; 34(2):251-269. PubMed ID: 37968171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity measures, metabolic health and their association with 15-year all-cause and cardiovascular mortality in the SAMINOR 1 Survey: a population-based cohort study.
    Michalsen VL; Wild SH; Kvaløy K; Svartberg J; Melhus M; Broderstad AR
    BMC Cardiovasc Disord; 2021 Oct; 21(1):510. PubMed ID: 34674643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.